the aid library

LIST OPTIONS

Filter

2829

Reseña normativa de la OMS: mantenimiento de las medidas de prevención y control de la COVID-19 en los establecimientos de salud, 14 de septiembre de 2022

Organización Mundial de la Salud OMS (2022) C_WHO

This document aims to encourage countries to develop and implement policies to maintain and strengthen IPC programmes and measures in health care facilities in the context of the current ongoing transmission of the SARS-CoV-2, with recognition that epidemiological trends may vary and the risk of tra... more

Download (159)

View PDF (200)

Reopening with Resilience: Lessons from remote learning during COVID-19

UNICEF (2021) C_UNICEF

The COVID-19 pandemic led to school closures around the world, affecting almost 1.6 billion students. The effects of even short disruptions in a child’s schooling on their learning and well-being have been shown to be acute and long lasting. The capacities of education systems to respond to the cr... more

Download (276)

View PDF (273)

Standard operating procedure (SOP) for health care in COVID-19 first line treatment centres (CFLTC)

Department of Health & Family Welfare Government of Kerala (2020) CC

Download (187)

View PDF (279)

What people living with HIV need to know about HIV and COVID-19

UNAIDS (2020) CC

COVID-19 is a serious disease and all people living with HIV should take all recommended preventive measures to minimize exposure to, and prevent infection by, the virus that causes COVID-19. As in the general population, older people living with HIV or people living with HIV with heart or lung prob... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (130)

View PDF (177)

Covid-19 in Brazil in 2020: impact on deaths from cancer and cardiovascular diseases

Cordeiro Jardim, B.; et al. (2022) CC

Rev Saude Publica. 2022; 56: 22. Published online 2022 Apr 11. doi: 10.11606/s1518-8787.2022056004040

Download (150)

View PDF (240)

Joint Statement on Dose Donations of COVID-19 Vaccines to African Countries

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

Download (358)

View PDF (239)

Safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women

World Health Organization WHO (2021) C_WHO

COVID-19 Vaccines: 1 Safety Surveillance 2 Manual While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn... more

Download (178)

View PDF (228)

Afghanistan: Agricultural livelihoods and food security in the context of COVID-19

Food and Agriculture Organization of the United Nations FAO (2021) CC

This survey of agricultural livelihoods and food security in the context of the impact of coronavirus disease 2019 (COVID-19) and other shocks was undertaken during February 2021 by the Food and Agriculture Organization of the United Nations (FAO) in 1 380 villages within 129 districts of 20 provinc... more

External Link

Prevalence and Factors Associated with Mental Health Impact of COVID-19 Pandemic in Bangladesh: A Survey-Based Cross- Sectional Study

Abir, T.; et al. (2021) CC

Annals of Global Health, 87(1), p.43. DOI: http://doi.org/10.5334/aogh.3269; The aim of this study was to examine the prevalence of mental health symptoms (anxiety, depression, and stress) in Bangladesh and the factors associated with these symptoms during the COVID-19 pandemic. They found that ... more

Download (153)

View PDF (169)

ECDC statement on the rapid increase of COVID-19 cases in Italy

European Centre for Disease Prevention and Control ECDC (2020) C1

Download (237)

View PDF (207)

COVID-19 rapid guideline: managing the long-term effects of COVID-19

NICE (2021) CC

This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of a... more

External Link

Bearing the brunt of covid-19: older people in low and middle income countries

P. Lloyd-Sherlock; S. Ebrahim; L. Geffen; et al. BMJ (2020) C2

BMJ 2020;368:m1052 doi: 10.1136/bmj.m1052 (Published 13 March 2020)

Download (204)

View PDF (247)

Managing the Pandemic and Its Aftermath: Economies, Jobs, and International Migration in the Age of COVID-19

Migration Policy Institute (2020) C1

The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f... more

Download (230)

View PDF (317)

Providing palliative care during the COVID-19 pandemic Experiences from Spain

World Health Organization WHO (2020) C_WHO

During theC OVID-19 crisis, the hospital observed a reduction of about 50% in inpatient visits for palliative care. Some patients postponed appointments given the risk of potential infection. Instead of in-person visits, weekly phone calls and remote follow-up were given priority.Palliative care is ... more

Download (580)

View PDF (177)

Guide for the preparation of a risk communication strategy for COVID-19 vaccines: A Resource for the countries of the Americas

Pan American Health Organisation PAHO (2021) C_WHO

This document facilitate the preparation of a risk communication and community engagement strategy for vaccination against COVID-19. Its goal is to help to strengthen the communication and planning capacities of the ministries or secretariats of health and other agencies in charge of communicating ... more